InsidersTradesSigma
Track the 蓝帆医疗 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 蓝帆医疗 has published 5 public disclosures. Market capitalisation: €5.9bn. The latest transaction was reported on 20 March 2026 (Purchase). Among the most active insiders: 于苏华. Every trade is openly available.
5
Insider Decl.
n/a
Thresholds
€681,912
3 ops.
Buy Volume
€1,929
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,712 of 29,064 companies
19.8
score / 100
Value23
Quality16
FCF yld-1.6%
Earn yld-13%
EV/EBITDA·
ROE-8.8%
Gross mgn16%
Net mgn-13%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 March 2026
Declarations5 total
5 of 5 declarations
关于 蓝帆医疗
蓝帆医疗是一家专注于医疗保健和制药领域的公司，提供医疗产品和医疗保健解决方案。该公司在XSHE市场上市。